Antibiotics in Our Food System
The rise of dangerous antibiotic-resistant bacteria have become a critical public health problem, fueled in part by their use in industrial animal agriculture. Since the 1940s, antibiotics have played a critical role in protecting public health, and have saved millions of lives. However, the non-therapeutic use of antibiotics by the is now responsible for the emergence of drug-resistant bacteria that pose a grave threat to public health. According to the FDA, more than 20 million pounds of medically important antibiotic drugs modern food animal industry were sold for use in food producing farm animals in 2014.
Antibiotics have been used in livestock feed since the 1940s, when studies showed that the drugs caused animals to grow faster and put on weight more efficiently, increasing meat producers’ profits. Up until the recent past, when the FDA banned the practice, non-therapeutic antibiotics — those used for purposes other than treating disease — were routinely given to livestock, poultry and fish on industrial farms to promote faster growth.
As industrial farming has spread around the world, so, too, has the use of non-therapeutic antibiotics. One study estimates that global antimicrobial consumption will grow by 67 percent by 2030, due to increasing demand for animal-based products, with countries including Brazil, India and China doubling their usage over that time period. According to the World Health Organization, antibiotic-resistance in many areas of the world already exceeds 50 percent in many major bacteria groups, including E. coli, K. pneumonia and S. aureus.
Related Conference of Antibiotics in Our Food System
7th International Conference on Applied Microbiology and Infectious Diseases
8th International Conference on Clinical Microbiology, Virology and Infectious Diseases
21st International Conference on Microbial Interactions & Microbial Ecology
12th International Congress on Trauma, Critical Care and Emergency Medicine
Antibiotics in Our Food System Conference Speakers
Recommended Sessions
- Bacterial Genomics
- Advances in Antimicrobials, Vaccines and therapeutics
- Alternatives to Antibiotics
- Antibiotic Prophylaxis
- Antibiotic Regulatory Affairs
- Antibiotic Resistance
- Antibiotic sensitivity
- Antibiotics in Chronic Respiratory Diseases
- Antibiotics in Oncology
- Antibiotics in Our Food System
- Antibiotics: Market Analysis & Business Opportunities
- Anticancer Antibiotics
- Bacterial Biochemistry
- Bacterial Clinical Studies
- Bacterial Ecology
- Bacterial Identification Methods
- Bacterial infections
- Bacterial pathogenesis
- Bacterial physiology
- Bacterial Vaccine
- Bacterial vaginosis
- Bacteriology in Public Health
- Bacteriology of dental infections
- Clinical Bacteriology
- Clinical Trials of Antibiotics
- Emerging Infectious Diseases
- Food Poisoning Bacteria
- Medical Bacteriology and Immunology
- Medical Use of Antibiotics
- Microbial Pathogenesis
- MRSA
- Multi Pathogen Infections
- Naturopathy for Bacterial Infections
- Next-Generation Antibiotics
- Pharmacology of antibiotics
- Plant Bacteriology
- Toxicity of antibiotics
- Urinary Tract Infection (UTI)
Related Journals
Are you interested in
- Acute Care Surgery - TRAUMA 2026 (France)
- Advances in Anti-Seizure Medications - EPILEPSY SUMMIT 2026 (France)
- Advances in Epilepsy Research and Treatment - EPILEPSY SUMMIT 2026 (France)
- Advances in Mood Stabilizers for Bipolar Disorder - EPILEPSY SUMMIT 2026 (France)
- Agriculture & Forest Microbiology - Microbial Interactions 2026 (France)
- Antimicrobial Agents & Resistance - Microbial Interactions 2026 (France)
- Applied and Environmental Science - Microbial Interactions 2026 (France)
- Aquatic & Marine Microbiology - Microbial Interactions 2026 (France)
- Bipolar Disorder and Suicidality: Risk Assessment and Management - EPILEPSY SUMMIT 2026 (France)
- Bipolar Disorder: Current Understanding and Future Directions - EPILEPSY SUMMIT 2026 (France)
- Bipolar Disorder: New Diagnostic Criteria and Tools - EPILEPSY SUMMIT 2026 (France)
- Burns and Thermal Injuries - TRAUMA 2026 (France)
- Cardiac and Vascular Emergencies - TRAUMA 2026 (France)
- Cellular Microbiology & Systems Microbiology - Microbial Interactions 2026 (France)
- Clinical and Public Health Microbiology - Microbial Interactions 2026 (France)
- Cognitive and Behavioral Effects of Epilepsy - EPILEPSY SUMMIT 2026 (France)
- Critical Care Medicine - TRAUMA 2026 (France)
- Drug-Resistant Epilepsy: Current Challenges and Solutions - EPILEPSY SUMMIT 2026 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2026 (France)
- Emerging Infectious Diseases in Critical Care - TRAUMA 2026 (France)
- Epilepsy in Pediatrics: Management and Outcomes - EPILEPSY SUMMIT 2026 (France)
- Epilepsy Surgery: Latest Innovations and Techniques - EPILEPSY SUMMIT 2026 (France)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2026 (France)
- Exploring Epilepsy and Mental Health Comorbidities - EPILEPSY SUMMIT 2026 (France)
- Food & Marine Microbiology - Microbial Interactions 2026 (France)
- Genetic and Epigenetic Factors in Bipolar Disorder - EPILEPSY SUMMIT 2026 (France)
- Geriatric Trauma and Emergency Care - TRAUMA 2026 (France)
- Global Health and Trauma Care - TRAUMA 2026 (France)
- Host-Pathogen Interaction - Microbial Interactions 2026 (France)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbial Interactions 2026 (France)
- Innovations and Technology in Trauma and Critical Care - TRAUMA 2026 (France)
- Integrative Approaches in Managing Epilepsy and Bipolar Disorder - EPILEPSY SUMMIT 2026 (France)
- Microbial Biodegradation - Microbial Interactions 2026 (France)
- Microbial Community - Microbial Interactions 2026 (France)
- Microbial Diseases - Microbial Interactions 2026 (France)
- Microbial Ecology and Evolution - Microbial Interactions 2026 (France)
- Microbial Interactions - Microbial Interactions 2026 (France)
- Microbial Pathogenesis - Microbial Interactions 2026 (France)
- Microbiology & Infectious Diseases - Microbial Interactions 2026 (France)
- Military and Combat Trauma - TRAUMA 2026 (France)
- Molecular Microbiology - Microbial Interactions 2026 (France)
- Mycology, Fungal Pathogens and Associated Diseases - Microbial Interactions 2026 (France)
- Neuroimaging in Bipolar Disorder Research - EPILEPSY SUMMIT 2026 (France)
- Neuroimaging Techniques in Epilepsy - EPILEPSY SUMMIT 2026 (France)
- Neurological Emergencies and Trauma - TRAUMA 2026 (France)
- Novel Biomarkers in Epilepsy Diagnosis - EPILEPSY SUMMIT 2026 (France)
- Pediatric and Neonatal Emergency Care - TRAUMA 2026 (France)
- Pharmacological Treatments for Bipolar Disorder - EPILEPSY SUMMIT 2026 (France)
- Plant Pathology & Microbiology - Microbial Interactions 2026 (France)
- Plant-Soil Microbe Interactions - Microbial Interactions 2026 (France)
- Psychosocial Aspects of Trauma and Critical Care - TRAUMA 2026 (France)
- Psychosocial Interventions in Bipolar Disorder - EPILEPSY SUMMIT 2026 (France)
- Resuscitation and Emergency Response - TRAUMA 2026 (France)
- Soil microbiology & Water Microbiology - Microbial Interactions 2026 (France)
- The Impact of Bipolar Disorder on Quality of Life - EPILEPSY SUMMIT 2026 (France)
- The Role of Genetics in Epilepsy - EPILEPSY SUMMIT 2026 (France)
- Trauma and Emergency Care Research - TRAUMA 2026 (France)
- Trauma and Emergency Medicine - TRAUMA 2026 (France)
- Trauma and Emergency Medicine Education - TRAUMA 2026 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2026 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2026 (France)
